Superbugs and Solutions

Superbugs pose a dire threat, with millions of lives at risk due to drug-resistant infections, particularly among vulnerable cancer patients. The financial toll could reach $100 trillion by 2050, yet there is hope; investing $42 billion over a decade in new antibiotics and infection prevention could dramatically change the landscape. Proactive measures in diagnostics and treatments are essential to safeguard both lives and healthcare systems.